Liberty One Investment Management LLC grew its position in shares of Elevance Health, Inc. (NYSE:ELV - Free Report) by 13.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,079 shares of the company's stock after buying an additional 1,096 shares during the period. Liberty One Investment Management LLC's holdings in Elevance Health were worth $3,349,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in ELV. Raelipskie Partnership bought a new stake in Elevance Health during the 3rd quarter valued at $26,000. PSI Advisors LLC purchased a new position in shares of Elevance Health in the third quarter valued at $27,000. Eastern Bank bought a new stake in shares of Elevance Health during the 3rd quarter valued at $31,000. Dunhill Financial LLC raised its stake in shares of Elevance Health by 57.8% during the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company's stock valued at $37,000 after purchasing an additional 26 shares during the period. Finally, Peterson Financial Group Inc. bought a new position in Elevance Health in the 3rd quarter worth about $44,000. Institutional investors own 89.24% of the company's stock.
Elevance Health Price Performance
Shares of Elevance Health stock traded down $1.00 during trading on Monday, hitting $384.26. 2,696,400 shares of the stock traded hands, compared to its average volume of 1,457,754. Elevance Health, Inc. has a 52 week low of $362.21 and a 52 week high of $567.26. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. The firm's fifty day moving average is $388.02 and its 200-day moving average is $466.18. The stock has a market cap of $89.12 billion, a price-to-earnings ratio of 14.01, a PEG ratio of 1.08 and a beta of 0.84.
Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The company reported $8.37 earnings per share for the quarter, missing analysts' consensus estimates of $9.66 by ($1.29). Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The business had revenue of $44.72 billion during the quarter, compared to the consensus estimate of $43.47 billion. During the same quarter in the previous year, the firm posted $8.99 earnings per share. The company's revenue was up 5.3% compared to the same quarter last year. Research analysts expect that Elevance Health, Inc. will post 32.96 EPS for the current fiscal year.
Analyst Ratings Changes
Several brokerages have recently weighed in on ELV. Argus cut Elevance Health from a "buy" rating to a "hold" rating in a research report on Friday, October 18th. Stephens reaffirmed an "underperform" rating on shares of Elevance Health in a report on Friday, October 18th. Cantor Fitzgerald cut their price target on shares of Elevance Health from $600.00 to $485.00 and set an "overweight" rating for the company in a report on Friday, October 18th. Royal Bank of Canada decreased their price target on shares of Elevance Health from $585.00 to $478.00 and set an "outperform" rating on the stock in a report on Friday, October 18th. Finally, Raymond James set a $485.00 price objective on Elevance Health in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $536.53.
Check Out Our Latest Stock Report on ELV
Elevance Health Company Profile
(
Free Report)
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Read More
Before you consider Elevance Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elevance Health wasn't on the list.
While Elevance Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.